- DSpace Home
- Browsing by Author
Browsing by Author "Dierssen Sotos, Trinidad"
Now showing items 1-6 of 6
-
Adequacy of early‑stage breast cancer systemic adjuvant treatment to Saint Gallen‑2013 statement: the MCC‑Spain study
Gómez Acebo, Inés; Dierssen Sotos, Trinidad; Mirones, Mónica; Alguacil Ojeda, Juan(Nature Research, 2021-03)
The St Gallen Conference endorsed in 2013 a series of recommendations on early breast cancer treatment. The main purpose of this article is to ascertain the clinical factors associated with St Gallen-2013 recommendations ... -
Changes in individual and contextual socioeconomic level influence on reproductive behavior in Spanish women in the MCCSpain study
Gómez Acebo, Inés; Dierssen Sotos, Trinidad; Palazuelos, Camilo; Alguacil Ojeda, Juan(BMC, 2020-03)
Background: The association between socioeconomic level and reproductive factors has been widely studied. For example, it is well known that women with lower socioeconomic status (SES) tend to have more children, the ... -
Dietary Constituents: Relationship with Breast Cancer Prognostic (MCC-SPAIN Follow-Up)
Dierssen Sotos, Trinidad; Gómez Acebo, Inés; Gutiérrez Ruiz, Nuria; Alguacil Ojeda, Juan(MDPI, 2020-12)
The aim of this study was to characterize the relationship between the intake of the major nutrients and prognosis in breast cancer. A cohort based on 1350 women with invasive (stage I-IV) breast cancer (BC) was followed ... -
Epidemiology of non-steroidal antiinflammatory drugs consumption in Spain. The MCC-Spain study
Gómez Acebo, Inés; Dierssen Sotos, Trinidad; Pérez Gómez, Beatriz; Capelo Álvarez, Rocío(BMC, 2018-09)
Background: Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used despite their risk of gastrointestinal bleeding or cardiovascular events. We report the profile of people taking NSAIDs in Spain, and we ... -
Validating a breast cancer score in Spanish women. The MCC-Spain study
Dierssen Sotos, Trinidad; Gómez Acebo, Inés; Palazuelos, Camilo; Bayo Calero, Juan Lucas; Llorca, Javier (Nature Research, 2018-02)A breast-risk score, published in 2016, was developed in white-American women using 92 genetic variants (GRS92), modifiable and non-modifiable risk factors. With the aim of validating the score in the Spanish population, ...